Fri, March 31, 2023

Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023

Jonathan Wolleben of JMP Securities, Reiterated "Altimmune, Inc." (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023.

Jonathan has made no other calls on ALT in the last 4 months.



There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, March 22nd, 2023


These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, March 9th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023